Figure 4. ISO-092 does not prevent diabetes in NOD mice.

Non-diabetic female NOD mice (n=33-34/group) at 12 weeks of age were administered ISO-092 or vehicle once daily by oral gavage for up to 14 days or diabetes onset.

Non-diabetic female NOD mice (n=33-34/group) at 12 weeks of age were administered ISO-092 or vehicle once daily by oral gavage for up to 14 days or diabetes onset.